Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man
- PMID: 2776822
- DOI: 10.1007/BF00637749
Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man
Abstract
Ten healthy male volunteers were given trimethadione (TMO) 4 mg/kg and antipyrine (AP) 500 mg alone or concomitantly to determine whether the metabolism of the drugs was mediated by the same or closely related forms of cytochrome P-450. Whether administered alone or together the clearance (CL) and half-life (t 1/2) of TMO and AP were the same, and there was a good correlation between the CL and t 1/2 of TMO and AP (alone r = 0.755 and 0.623, respectively; coadministered r = 0.771 and 0.503, respectively). Excretion of AP and its main metabolite and the clearance for production of AP metabolites after AP was administered alone were not significantly different when TMO and AP were taken together. When the two drugs were administered alone or coadministered, the correlation between the CL of TMO and the excretion of 3-hydroxymethyl-3-norantipyrine (NORA) was close (alone r = 0.734, coadministered r = 0.749). The correlation between the CL of TMO and CLm of NORA when TMO and AP were given alone or concomitantly was 0.762 and 0.772, respectively. The findings suggest that TMO metabolism and the formation of NORA in healthy subjects are mediated by a closely related form(s) of the cytochrome P-450 system.
Similar articles
-
A method for estimation of hepatic drug-metabolizing capacity: determination of concentration of trimethadione and its metabolite in human serum.J Pharmacobiodyn. 1984 May;7(5):329-35. doi: 10.1248/bpb1978.7.329. J Pharmacobiodyn. 1984. PMID: 6470930
-
The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.J Pharmacobiodyn. 1985 Sep;8(9):773-9. doi: 10.1248/bpb1978.8.773. J Pharmacobiodyn. 1985. PMID: 4087137
-
Dual effects of a novel thienodiazepine platelet-activating factor antagonist, on drug-oxidizing enzymes in beagle dog.Xenobiotica. 1994 Apr;24(4):293-300. doi: 10.3109/00498259409045893. Xenobiotica. 1994. PMID: 8059533
-
Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans.Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996 Nov;115(3):211-6. doi: 10.1016/s0742-8413(96)00102-8. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996. PMID: 9375358 Review.
-
Trimethadione metabolism as a probe drug to estimate hepatic oxidizing capacity in rats.Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993 Feb;104(2):205-7. doi: 10.1016/0742-8413(93)90025-g. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993. PMID: 8098675 Review.
Cited by
-
The potential of the South African plant Tulbaghia Violacea Harv for the treatment of triple negative breast cancer.Sci Rep. 2025 Feb 17;15(1):5737. doi: 10.1038/s41598-025-88417-2. Sci Rep. 2025. PMID: 39962120 Free PMC article.
-
Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity.J Gastroenterol. 1995 Aug;30(4):478-84. doi: 10.1007/BF02347564. J Gastroenterol. 1995. PMID: 7550858
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources